Who owns BIOLINE RX LIMITED SPONSORED ADR?
- Ticker: BLRX
- CUSIP Number: 09071m304
Tip: Access positions for across all investors
Analyze quarterly positions in Bioline Rx with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Bioline Rx stock
Who bought or sold BIOLINE RX LIMITED SPONSORED ADR this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Citadel Advisors | 10k | $38k | -86% | Sep 2025 |
|
| Rhumbline Advisers | 3.4k | $9.6k | 9% | Dec 2025 |
|
| UBS Group | 2.0k | $5.4k | -69% | Dec 2025 |
|
| Wells Fargo & Company | 1.8k | $4.8k | 0% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 1.5k | $4.2k | 100% | Dec 2025 |
|
| Nemes Rush Group | 250.00 | $693.000000 | 0% | Dec 2025 |
|
| Goss Wealth Management | 107.00 | $296.004800 | 0% | Dec 2025 |
|
| Advisor Group Holdings | 26.00 | $71.000800 | 2500% | Dec 2025 |
|
| Rockefeller Capital Management | 12.00 | $33.000000 | 0% | Dec 2025 |
|
| Danske Bank A/s | 2.00 | $6.000000 | 0% | Dec 2025 |
|
| Banque Cantonale Vaudoise | 1.00 | $0 | 100% | Dec 2025 |
|
Who sold out of Bioline Rx?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Susquehanna International | Sep 2025 | 20k | $76k |
| Simplex Trading | Sep 2025 | 105.00 | $0 |
| Tower Research Capital | Sep 2025 | 39.00 | $146.998800 |
| SBI Securities | Sep 2025 | 2.00 | $8.000000 |